NovaBay Pharmaceuticals, Inc. Total Assets

Total Assets of NBY for past 10 years: annual, quarterly and twelve month trailing (TTM) including Total Assets growth rates and interactive chart. Total assets are the sum of all current and noncurrent assets and must equal the sum of total liabilities and stockholders' equity combined. In the accounting industry, assets are defined as anything that a business owns, has value, and can be converted to cash.


Highlights and Quick Summary

  • Total Assets for the quarter ending June 30, 2022 was $21.5 Million (a -13.11% decrease compared to previous quarter)
  • Year-over-year quarterly Total Assets increased by 76.03%
  • Annual Total Assets for 2021 was $24 Million (a -50.3% decrease from previous year)
  • Annual Total Assets for 2020 was $48.2 Million (a 329.97% increase from previous year)
  • Annual Total Assets for 2019 was $11.2 Million (a 19.86% increase from previous year)
Visit stockrow.com/NBY for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow statement with 10 years of data, and state-of-the-art screener.

Historical Total Assets of NovaBay Pharmaceuticals, Inc.

Most recent Total Assetsof NBY including historical data for past 10 years.

Interactive Chart of Total Assets of NovaBay Pharmaceuticals, Inc.

NovaBay Pharmaceuticals, Inc. Total Assets for the past 10 Years (both Annual and Quarterly)

(All values are in $ million)

Year Q1 Q2 Q3 Q4 Fiscal Year
2022 $21.54 $24.79
2021 $23.98 $12.24 $13.6 $14.07 $23.98
2020 $15.24 $17.08 $13.27 $9.48 $48.24
2019 $11.22 $14.6 $9.87 $9.72 $11.22
2018 $9.36 $10.37 $11.71 $13.82 $9.36
2017 $10.08 $11.06 $12.07 $12.68 $10.08
2016 $15.38 $15.14 $7.01 $4.93 $15.38
2015 $5.08 $6.69 $10.17 $8.16 $5.08
2014 $7.54 $11.04 $13.51 $17.19 $7.54
2013 $15.65 $12.25 $12.83 $15.42 $15.65
2012 $19.24 $13.67 $12.07 $14.04 $19.24
2011 $15.96 $18.3 $15.96

Business Profile of NovaBay Pharmaceuticals, Inc.

Sector: Healthcare
Industry: Biotechnology